Visual

Thallion Pharmaceuticals Inc. is a biotechnology company focussed on developing new treatments for under-served markets in oncology and infectious disease.

Events

July 14, 2008

2008 Q2 Earnings Announcement and Webcast

July 6 - 11, 2008

Poster Presentation at a Gordon Research Conference

›› more

News

July 10, 2008

Thallion Announces 2008 Second Quarter Results

July 7, 2008

Notice of Thallion Pharmaceuticals Fiscal 2008 Second Quarter Conference Call

June 26, 2008

Thallion receives health canada approval to initiate Phase II study for TLN-232 in metastatic melanoma patients- Company initiates Phase II study with its second oncology product -

›› archives